Aliment Pharmacol Ther

1. IDALSOAGA F, Diaz LA, Ayares G, Cabrera D, et al
   Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease-Authors' reply.
   Aliment Pharmacol Ther. 2024 Sep 2. doi: 10.1111/apt.18246.
   

   >> Share

   
   
2. KOUNTOURAS J, Vardaka E, Zavos C, Chatzopoulos D, et al
   Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease.
   Aliment Pharmacol Ther. 2024 Sep 2. doi: 10.1111/apt.18220.
   

   >> Share

   
   

   
   BMC Gastroenterol

3. WANG C, Wang J, Fang M, Fei B, et al
   Genetic evidence causally linking gastroesophageal reflux disease to cholecystitis: a two-sample mendelian randomization study.
   BMC Gastroenterol. 2024;24:301.
   

   >> Share

   
   

   
   Dig Dis Sci

4. ZHOU R, Li W, Wu F, Sheng Y, et al
   Does Gastroesophageal Reflux Disease Increase the Risk of Sepsis and Its 28-day Mortality? A Causal Study Using a Mendelian Randomization Approach.
   Dig Dis Sci. 2024 Sep 4. doi: 10.1007/s10620-024-08625.
   

   >> Share

   
   

   
   Gastroenterology

5. HOFT SG, Brennan M, Carrero JA, Jackson NM, et al
   UNVEILING CANCER-RELATED METAPLASTIC CELLS IN BOTH HELICOBACTER PYLORI INFECTION AND AUTOIMMUNE GASTRITIS.
   Gastroenterology. 2024 Sep 3:S0016-5085(24)05415.
   

   >> Share

   
   

   
   J Ethnopharmacol

6. ZHANG YL, Li Y, An FX, Sun CY, et al
   Peucedanum praeruptorum Dunn leaf aqueous extract protects against alcoholic gastric injury by inhibiting inflammation and oxidative stress in mice.
   J Ethnopharmacol. 2024;335:118628.
   

   >> Share

   
   
7. LIN K, Wang Z, Wang E, Zhang X, et al
   Targeting TRPV1 signaling: Galangin improves ethanol-induced gastric mucosal injury.
   J Ethnopharmacol. 2024;335:118605.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share